Natural Health Trends Corp. (NHTC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value 0.26%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.26% | Share-based compensation / revenue. Period ending 2026-03-31. $98.00K ÷ $38.24M × 100 ≈ 0.26% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 38.24M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 98.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -1.94M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | (m) | $38.24M | $98.00K | $-1.94M | (m) | (m) | 0.26% | (m) | (m) |
| 2025-12-31 | (m) | $39.78M | $132.00K | $-1.81M | (m) | (m) | 0.33% | (m) | (m) |
| 2025-09-30 | (m) | $40.87M | $139.00K | $-1.59M | (m) | (m) | 0.34% | (m) | (m) |
| 2025-06-30 | (m) | $42.09M | $138.00K | $-1.37M | (m) | (m) | 0.33% | (m) | (m) |
| 2025-03-31 | (m) | $42.75M | $142.00K | $-1.28M | (m) | (m) | 0.33% | (m) | (m) |
| 2024-12-31 | (m) | $42.96M | $145.00K | $-1.30M | (m) | (m) | 0.34% | (m) | (m) |
| 2024-09-30 | (m) | $43.05M | $147.00K | $-1.12M | (m) | (m) | 0.34% | (m) | (m) |
| 2024-06-30 | (m) | $42.98M | $151.00K | $-1.14M | (m) | (m) | 0.35% | (m) | (m) |
| 2024-03-31 | (m) | $43.01M | $152.00K | $-1.64M | (m) | (m) | 0.35% | (m) | (m) |
| 2023-12-31 | (m) | $43.92M | $161.00K | $-1.67M | (m) | (m) | 0.37% | (m) | (m) |
| 2023-09-30 | (m) | $45.50M | (m) | $-1.39M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $46.60M | (m) | $-1.24M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $49.45M | (m) | $-281.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $49.13M | (m) | $-270.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $52.73M | (m) | $174.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $55.29M | (m) | $798.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $58.08M | (m) | $968.00K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $60.01M | (m) | $1.57M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $60.49M | (m) | $2.35M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $60.34M | (m) | $2.54M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $60.59M | (m) | $2.34M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $62.07M | (m) | $669.00K | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $63.31M | (m) | $-3.84M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $66.21M | (m) | $-5.58M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $73.23M | (m) | $-5.76M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $77.61M | (m) | $-7.02M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $101.37M | (m) | $1.96M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $131.39M | (m) | $10.87M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $158.87M | (m) | $20.98M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $191.91M | $0.00 | $33.73M | (m) | (m) | 0.00% | (m) | (m) |
| 2018-09-30 | (m) | (m) | $9.00K | $36.69M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $18.00K | $37.35M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | $26.00K | $40.11M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $35.00K | $43.06M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | $36.00K | $54.39M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $37.00K | $61.08M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $39.00K | $63.14M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $104.00K | $64.14M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $124.00K | $58.02M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $135.00K | $57.61M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $145.00K | $54.95M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $86.00K | $47.88M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $63.00K | $40.05M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $50.00K | $30.71M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $39.00K | $24.62M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $49.00K | $20.82M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | $70.00K | $16.41M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $91.00K | $12.27M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | $105.00K | $7.05M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $110.00K | $4.22M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | $116.00K | $2.98M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $107.00K | $2.44M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | $104.00K | $2.39M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $94.00K | $2.65M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | $82.00K | $2.51M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | $84.00K | $2.95M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | $85.00K | $2.71M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $79.00K | $1.78M | $16.00K | (m) | (m) | 111.44× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $175.00K | $-3.08M | $18.00K | (m) | (m) | -171.06× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDUCATIONAL DEVELOPMENT CORP (EDUC) | United States | $0.011B | |
| HYDROFARM HOLDINGS GROUP, INC. (HYFM) | United States | $0.005B | -0.01 |
| Vestis Corp (VSTS) | United States | $1.828B | -356.33 |